CALGARY -- When Madden Ellis Garraway was just under two-years-old, he became very sick.
His skin was so dry it bled and he couldn’t hold down food, causing his weight dropped to within ounces of his birth weight of seven pounds, six ounces.
Doctors struggled to figure out what was wrong.
“We had a large list of things that we were thinking of, and our immunology team and my colleagues who are working with Madden were having trouble arriving at the right one," said Dr. Francois Bernier, head of the Department of Medical Genetics and a professor in the Department of Paediatrics at the University of Calgary's Cumming School of Medicine.
"In fact, we made some attempts to arrive at a diagnosis but we're still unsure. It took a while.”
Doctors often struggle with diagnosing unusual health issues, especially those that may require genetic testing.
They often must rely on genome sequencing tests to determine the root cause of a disease and until now, large-scale genome sequencing tests were often sent to labs in the United States for analysis.
Bernier calls it "the diagnostic odyssey," a long, difficult, journey for families waiting while clinicians figure out what is causing the underlying health issues.
Madden Garraway in hospital at the age of two. (Photo courtesy the Garraway family)
Madden’s family can attest to that.
It was months of waiting, wondering and worrying before Madden's blood was sent to a U.S. lab for genome analysis, where it was learned he suffered from a rare genetic condition called immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome.
IPEX is a rare genetic disorder that can be life threatening.
"If we could have learned about that instantly, or within the several weeks that we can do now, that will save a lot of time," said Madden’s father, Patrick Garraway.
"We could have got on with his bone marrow transplant sooner."
Madden received a bone marrow transplant from his sister. Now five-years-old, the playful youngster has made a full recovery and no longer requires medication.
"There are so many families waiting for answers to serious medical conditions," said Bernier.
"Access to gene sequencing early in the medical journey can pinpoint the best treatment approaches and therapies to target the illness."
Madden Garraway today at the age of five. (Photo courtesy the Garraway family)
A new partnership struck between the University of Calgary, University of Alberta, and Alberta Precision Laboratories will help families and medical professionals answer to those diagnostic puzzles sooner.
The partnership is funded by Genome Canada, the Alberta Children’s Hospital Foundation, and other partners. Four other centres in Canada are also undertaking similar programs through Genome Canada’s funding, one in B.C., two in Ontario and one in Quebec.
